Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Xiao-cheng Lin"'
Publikováno v:
Clinical Case Reports, Vol 12, Iss 6, Pp n/a-n/a (2024)
Key Clinical Message One Kirsten Ras (KRAS) G12C mutated non‐small cell lung cancer (NSCLC) patient had improved poor performance status and obtained mixed response with the first‐line KRAS‐targeted treatment of sotorasib. After disease progres
Externí odkaz:
https://doaj.org/article/89f10a8829094f05b0d06ae51516c8b3
Autor:
Mei-Mei Fang, Jiang-Tao Cheng, Yu-Qing Chen, Xiao-Cheng Lin, Jun-Wei Su, Yi-Long Wu, Hua-Jun Chen, Jin-Ji Yang
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Some studies of dual-targeted therapy (DTT) targeting epidermal growth factor receptor (EGFR) and mesenchymal-epithelial transition (MET) have shown promising efficacy in non-small-cell lung cancer (NSCLC). Consequently, patient managemen
Externí odkaz:
https://doaj.org/article/4b62238d2afd45e6bcf4a0bf48a53e7e
Autor:
Jun-Wei Su, Cheng-Di Weng, Xiao-Cheng Lin, Mei-Mei Fang, Xiao Xiao, Yi-Chen Zhang, Xu-Chao Zhang, Jian Su, Chong-Rui Xu, Hong-Hong Yan, Hua-Jun Chen, Yi-Long Wu, Jin-Ji Yang
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Mesenchymal–epithelial transition ( MET ) amplification is a crucial oncogenic driver and a resistance mechanism to epidermal growth factor receptor tyrosine kinase inhibitors (TKIs) of non-small-cell lung cancer (NSCLC). Fluorescence i
Externí odkaz:
https://doaj.org/article/0ef134b3e84a4a9f9ebf044f8db4c295
Autor:
Qing-Yun Gao, Fa-Man Xiao, Xiao-Cheng Lin, Yu-Qing Chen, Yu-Fa Li, Chang Lu, Jun-Wei Su, Quan-Quan Tan, Chan-Yuan Zhang, Jiao Yang, Yi-Long Wu, Hua-Jun Chen, Jin-Ji Yang
Publikováno v:
Cancer Treatment and Research Communications, Vol 35, Iss , Pp 100707- (2023)
Background: For patients with lung malignancies with RET rearrangement, the efficacy of immune checkpoint inhibitors is limited. The characteristics of the tumour immune microenvironment (TIME) and molecular pathological features of these patients ha
Externí odkaz:
https://doaj.org/article/023d31908c7f494ca5ccddf450d9803c
Autor:
Qiang Guo, Chen-Yang Liu, Ling-Jie Zheng, Shang-He Zheng, Ya-Xing Zhang, Su-Ying Zhao, Hui-Dong Zheng, Li-Hai Fan, Xiao-Cheng Lin
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 10 (2022)
D-Allulose is an ultra-low calorie sweetener with broad market prospects. As an alternative to Izumoring, phosphorylation-dephosphorylation is a promising method for D-allulose synthesis due to its high conversion of substrate, which has been prelimi
Externí odkaz:
https://doaj.org/article/6bca5746507b404c80a313defc737ecd
Publikováno v:
Guoji Yanke Zazhi, Vol 13, Iss 12, Pp 2504-2506 (2013)
AIM: To study the complications of phaco-cataract surgery.METHODS: Totally, 500 eyes underwent phaco-cataract surgery were retrospectively analysis from January 2008 to January 2011. RESULTS: In all 500 cases(500 eyes)with age-related cataract by pha
Externí odkaz:
https://doaj.org/article/d3337a2f7f2441a7969978d2c3295dd5
Autor:
Qing-Yun Gao, Fa-Man Xiao, Xiao-cheng Lin, Yu-Qing Chen, Yu-Fa Li, Chang Lu, Jun-Wei Su, Quan-Quan Tan, Chan-Yuan Zhang, Jiao Yang, Yi-Long Wu, Hua-Jun Chen, Jin-Ji Yang
Purpose For patients with lung malignancies with RET rearrangement, the efficacy of immune checkpoint inhibitors is limited. The characteristics of the tumour immune microenvironment (TIME) and molecular pathological features of these patients have n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31eac47eb256797e769b45c9502082fc
https://doi.org/10.21203/rs.3.rs-2397760/v1
https://doi.org/10.21203/rs.3.rs-2397760/v1
Autor:
Qiang, Guo, Chen-Yang, Liu, Ling-Jie, Zheng, Shang-He, Zheng, Ya-Xing, Zhang, Su-Ying, Zhao, Hui-Dong, Zheng, Li-Hai, Fan, Xiao-Cheng, Lin
Publikováno v:
Frontiers in bioengineering and biotechnology. 10
D-Allulose is an ultra-low calorie sweetener with broad market prospects. As an alternative to Izumoring, phosphorylation-dephosphorylation is a promising method for D-allulose synthesis due to its high conversion of substrate, which has been prelimi
Autor:
Yuqing Chen, Xu-Hui Guan, Ling-Ling Gao, Ling-Cong Kong, Huan Yang, Xiao-Cheng Lin, Mei-Mei Fang, Yu-Fa Li, Xuchao Zhang, Hui-Ying Liang, Jin-Ji Yang
Publikováno v:
Journal of Clinical Oncology. 40:8578-8578
8578 Background: IMpower133 showed benefits in both progression-free survival (PFS) and overall survival (OS) of etoposide/carboplatin plus atezolizumab (ECT) regimen in extensive-stage small-cell lung cancer (ES-SCLC), but the absolute benefit was l
Autor:
Nasheen Naidoo, Pei Wang, Wen Yu Yang, Chen Bin Wu, Jin Qin Ding, Jun Zhou, Xiao Cheng Lin, Hui Jun Zhou, Jin Tong Wu
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 12:359-368
Aim To identify the optimal strategy for gastric cancer (GC) prevention by evaluating the cost-effectiveness of esophagogastroduodenoscopy (EGD)-based preventive strategies. Methods We conducted a model-based cost-effectiveness analysis. Adopting a h